Biodesix
BDSX
29 hedge funds and large institutions have $20.7M invested in Biodesix in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
0% more ownership
Funds ownership: 1.07% → 1.07% (+0%)
3% less funds holding
Funds holding: 30 → 29 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
33% less capital invested
Capital invested by funds: $31M → $20.7M (-$10.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$377K |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$370K |
| 3 |
LCM
Legato Capital Management
San Francisco,
California
|
+$223K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$202K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$92.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$724K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$211K |
| 3 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$145K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$68.5K |
| 5 |
HF
HRT Financial
New York
|
-$61K |
BDSX Hedge Fund Activity: Q2 2023 in Review
29 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q2 2023, worth a combined $20.7M — down 33% from $31M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BDSX and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 10 added.
The largest buyer was State Street, adding an estimated $377K. The largest seller was AIGH Capital Management, cutting an estimated $724K.
- 29 institutional investors held Biodesix (BDSX) as of Q2 2023, down from 30 in Q1 2023.
- Funds reported $20.7M of Biodesix stock for Q2 2023, down 33% quarter-over-quarter.
- 4 funds opened new Biodesix positions in Q2 2023 and 5 closed out, a net change of -1 holder.
- The largest Biodesix buyer in Q2 2023 was State Street, an estimated $377K added.
- The largest Biodesix seller in Q2 2023 was AIGH Capital Management, an estimated $724K sold.
Based on aggregated 13F filings for Q2 2023.